Your browser doesn't support javascript.
loading
Deep learning enables robust assessment and selection of human blastocysts after in vitro fertilization.
Khosravi, Pegah; Kazemi, Ehsan; Zhan, Qiansheng; Malmsten, Jonas E; Toschi, Marco; Zisimopoulos, Pantelis; Sigaras, Alexandros; Lavery, Stuart; Cooper, Lee A D; Hickman, Cristina; Meseguer, Marcos; Rosenwaks, Zev; Elemento, Olivier; Zaninovic, Nikica; Hajirasouliha, Iman.
Afiliación
  • Khosravi P; 1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, New York, NY USA.
  • Kazemi E; 2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, New York, NY USA.
  • Zhan Q; 3Yale Institute for Network Science, Yale University, New Haven, CT USA.
  • Malmsten JE; 4The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY USA.
  • Toschi M; 4The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY USA.
  • Zisimopoulos P; 4The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY USA.
  • Sigaras A; 1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, New York, NY USA.
  • Lavery S; 2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, New York, NY USA.
  • Cooper LAD; 1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, New York, NY USA.
  • Hickman C; 2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, New York, NY USA.
  • Meseguer M; 5Institute of Reproduction and Developmental Biology, Imperial College, Hammersmith Campus, London, UK.
  • Rosenwaks Z; 6Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA.
  • Elemento O; 5Institute of Reproduction and Developmental Biology, Imperial College, Hammersmith Campus, London, UK.
  • Zaninovic N; 7Instituto Valenciano de Infertilidad, Universidad de Valencia, Valencia, Spain.
  • Hajirasouliha I; 4The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY USA.
NPJ Digit Med ; 2: 21, 2019.
Article en En | MEDLINE | ID: mdl-31304368
Visual morphology assessment is routinely used for evaluating of embryo quality and selecting human blastocysts for transfer after in vitro fertilization (IVF). However, the assessment produces different results between embryologists and as a result, the success rate of IVF remains low. To overcome uncertainties in embryo quality, multiple embryos are often implanted resulting in undesired multiple pregnancies and complications. Unlike in other imaging fields, human embryology and IVF have not yet leveraged artificial intelligence (AI) for unbiased, automated embryo assessment. We postulated that an AI approach trained on thousands of embryos can reliably predict embryo quality without human intervention. We implemented an AI approach based on deep neural networks (DNNs) to select highest quality embryos using a large collection of human embryo time-lapse images (about 50,000 images) from a high-volume fertility center in the United States. We developed a framework (STORK) based on Google's Inception model. STORK predicts blastocyst quality with an AUC of >0.98 and generalizes well to images from other clinics outside the US and outperforms individual embryologists. Using clinical data for 2182 embryos, we created a decision tree to integrate embryo quality and patient age to identify scenarios associated with pregnancy likelihood. Our analysis shows that the chance of pregnancy based on individual embryos varies from 13.8% (age ≥41 and poor-quality) to 66.3% (age <37 and good-quality) depending on automated blastocyst quality assessment and patient age. In conclusion, our AI-driven approach provides a reproducible way to assess embryo quality and uncovers new, potentially personalized strategies to select embryos.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: NPJ Digit Med Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: NPJ Digit Med Año: 2019 Tipo del documento: Article